Integra LifeSciences Reports Third Quarter 2023 Financial Results
PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2023.
- PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2023.
- The Company reported GAAP gross margin of 57.1%, compared to 61.5% in the third quarter of 2022.
- Adjusted EBITDA for the third quarter of 2023 was $88.1 million, or 23.0% of revenue, compared to $105.3 million, or 27.3% of revenue, in the prior year.
- ET on Wednesday, October 25, 2023, to discuss third quarter 2023 financial results and forward-looking financial guidance.